Hazlett, Burt & Watson’s Exact Sciences EXAS Stock Holding History

Hazlett, Burt & Watson’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400	Closed	-$41K	–	930
2025 Q4	$41K	Hold	400	–	–	0.01%	473
2025 Q3	$22K	Hold	400	–	–	0.01%	544
2025 Q2	$21K	Hold	400	–	–	0.01%	493
2025 Q1	$17K	Buy	+400	New	+$20.3K	0.01%	515

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Hazlett, Burt & Watson's EXAS Position: Q1 2026 in Review

Hazlett, Burt & Watson sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 400 shares — an estimated $41K sold.

Hazlett, Burt & Watson first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $41K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Hazlett, Burt & Watson reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Hazlett, Burt & Watson sold 400 Exact Sciences shares in Q1 2026, an estimated $41K.
Hazlett, Burt & Watson first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
Hazlett, Burt & Watson's Exact Sciences position peaked at $41K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.